Additional avenues of research on EGA should include its utilization as a broad-spectrum agent against viral and bacterial infection, as pointed out in its initial discovery (22), as well as assessment of its potential in autoimmune disease states where TLR9 is implicated in the disease pathogenesis. This evidence concerns the gene TLR9 and bacterial infectious disease.